- Home
- PLAG vs IMNN Comparison
PLAG vs IMNN Comparison
Compare PLAG & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLAG
- IMNN
- Stock Information
- Founded
- PLAG 1986
- IMNN 1982
- Country
- PLAG United States
- IMNN United States
- Employees
- PLAG N/A
- IMNN N/A
- Industry
- PLAG Packaged Foods
- IMNN Biotechnology: Pharmaceutical Preparations
- Sector
- PLAG Consumer Staples
- IMNN Health Care
- Exchange
- PLAG Nasdaq
- IMNN Nasdaq
- Market Cap
- PLAG 12.0M
- IMNN 12.1M
- IPO Year
- PLAG N/A
- IMNN 1985
- Fundamental
- Price
- PLAG $1.75
- IMNN $7.08
- Analyst Decision
- PLAG
- IMNN Buy
- Analyst Count
- PLAG 0
- IMNN 2
- Target Price
- PLAG N/A
- IMNN $210.00
- AVG Volume (30 Days)
- PLAG 124.1K
- IMNN 500.6K
- Earning Date
- PLAG 08-18-2025
- IMNN 08-05-2025
- Dividend Yield
- PLAG N/A
- IMNN N/A
- EPS Growth
- PLAG N/A
- IMNN N/A
- EPS
- PLAG N/A
- IMNN N/A
- Revenue
- PLAG $6,066,143.00
- IMNN N/A
- Revenue This Year
- PLAG N/A
- IMNN N/A
- Revenue Next Year
- PLAG N/A
- IMNN N/A
- P/E Ratio
- PLAG N/A
- IMNN N/A
- Revenue Growth
- PLAG N/A
- IMNN N/A
- 52 Week Low
- PLAG $0.47
- IMNN $4.83
- 52 Week High
- PLAG $5.52
- IMNN $41.22
- Technical
- Relative Strength Index (RSI)
- PLAG 55.31
- IMNN 42.63
- Support Level
- PLAG $1.50
- IMNN $6.45
- Resistance Level
- PLAG $1.94
- IMNN $8.19
- Average True Range (ATR)
- PLAG 0.21
- IMNN 0.83
- MACD
- PLAG 0.01
- IMNN 0.30
- Stochastic Oscillator
- PLAG 43.08
- IMNN 56.08
About PLAG Planet Green Holdings Corp.
Planet Green Holdings Corp is a diversified technology and consumer products company with a presence in North America and China engaged in Chemical Products, Tea Products, and Online Advertising Services. The company operates in three segments namely to grow, produce, and distribute Cyan brick tea, black tea, and green tea in China; to research, develop, manufacture, and sell chemical products including formaldehyde, urea formaldehyde adhesive, methylal, ethanol fuel, fuel additives and clean fuel in China; and to develop and operate a demand-side platform which empowers buyers of advertising to manage and optimize their digital advertising across different real-time bidding networks in North America and China.
About IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).